Foster Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
UBP
Foster Group's BMY Position: Q2 2026 in Review
Foster Group increased its Bristol-Myers Squibb (BMY) stake by 5.5% in Q2 2026, buying an estimated $12.9K and bringing the position to 4,281 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #274.
Foster Group first reported a position in BMY in Q4 2020 and has held it in 19 quarters since. The position peaked at $499K in Q4 2022. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Foster Group held 4,281 shares of Bristol-Myers Squibb worth $247K as of Q2 2026.
- Foster Group bought 224 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.9K.
- Bristol-Myers Squibb made up 0.01% of Foster Group's portfolio in Q2 2026, its #274 holding.
- Foster Group first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 19 quarters since.
- Foster Group's Bristol-Myers Squibb position peaked at $499K in Q4 2022.
- 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.